Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug;34(8):2980-2990.
doi: 10.1007/s11695-024-07381-4. Epub 2024 Jul 15.

Core Set of Patient-Reported Outcome Measures for Measuring Quality of Life in Clinical Obesity Care

Affiliations

Core Set of Patient-Reported Outcome Measures for Measuring Quality of Life in Clinical Obesity Care

Phillip J Dijkhorst et al. Obes Surg. 2024 Aug.

Abstract

Purpose: The focus of measuring success in obesity treatment is shifting from weight loss to patients' health and quality of life. The objective of this study was to select a core set of patient-reported outcomes and patient-reported outcome measures to be used in clinical obesity care.

Materials and methods: The Standardizing Quality of Life in Obesity Treatment III, face-to-face hybrid consensus meeting, including people living with obesity as well as healthcare providers, was held in Maastricht, the Netherlands, in 2022. It was preceded by two prior multinational consensus meetings and a systematic review.

Results: The meeting was attended by 27 participants, representing twelve countries from five continents. The participants included healthcare providers, such as surgeons, endocrinologists, dietitians, psychologists, researchers, and people living with obesity, most of whom were involved in patient representative networks. Three patient-reported outcome measures (patient-reported outcomes) were selected: the Impact of Weight on Quality of Life-Lite (self-esteem) measure, the BODY-Q (physical function, physical symptoms, psychological function, social function, eating behavior, and body image), and the Quality of Life for Obesity Surgery questionnaire (excess skin). No patient-reported outcome measure was selected for stigma.

Conclusion: A core set of patient-reported outcomes and patient-reported outcome measures for measuring quality of life in clinical obesity care is established incorporating patients' and experts' opinions. This set should be used as a minimum for measuring quality of life in routine clinical practice. It is essential that individual patient-reported outcome measure scores are shared with people living with obesity in order to enhance patient engagement and shared decision-making.

Keywords: Bariatric surgery; Clinical practice; Obesity treatment; Outcome reporting; Patient-reported outcome measures; Patient-reported outcomes; Quality of life.

PubMed Disclaimer

Conflict of interest statement

Claire E. E. de Vries and Valerie M. Monpellier founded the S.Q.O.T. initiative. The initiative was cofounded by Bart A. van Wagensveld, Ignace M. C. Janssen, and Ronald S. L. Liem. Phillip J Dijkhorst joined the board of the S.Q.O.T. initiative in 2021. Claire E. E. de Vries, Ronald S. L. Liem, and Lotte Poulsen were involved in developing the eating scales in the BODY-Q. Claire E.E. de Vries and Ronald S. L. Liem are members of the organizing committee and were not permitted to participate in, nor influence, discussions during the S.Q.O.T. consensus meetings or the voting rounds. Lotte Poulsen was not permitted to participate in the voting rounds if the BODY-Q was available for a specific patient-reported outcome domain. None of the aforementioned persons received financial compensation for developing the BODY-Q or for any other BODY-Q-related activity. Ignace M. C. Janssen was a consultant at Johnson & Johnson and the Dutch Obesity Clinic. Johan Ottosson previously sat on the advisory board of Novo Nordisk. The University of Leeds received payments for Professor Halford’s work on ACTION-Teens. Over the last 3 years, Stuart W. Flint reported research grants from the National Institute for Health Research, the Office of Health Improvement & Disparities, Public Health England, Doncaster Council, West Yorkshire Combined Authority, Johnson & Johnson, Novo Nordisk, and the University of Leeds. He reported receiving personal fees from the Royal College of General Practitioners and institutional fees from Public Health England, and he received funding to attend meetings at the parliament of the UK, Novo Nordisk, Johnson & Johnson, and Safefood. Stuart W. Flint also reported unpaid roles with Obesity UK. Bruno Halpern sat on the advisory boards of Novo Nordisk, Lilly, and Astra Zeneca. Additionally, he received lecture fees from Novo Nordisk, Astra Zeneca, Merck, and Abbott Nutrition. Furthermore, BH conducted clinical trials in collaboration with Novo Nordisk, Lilly, and Boehringer Ingelheim. John B. Dixon was a consultant at and sat on the advisory boards of Nestle Health Science and Reshape Lifesciences. He also sat on the advisory boards and also received speaker fees from Novo Nordisk and Lilly.

References

    1. Hruby A, Manson JE, Qi L et al. Determinants and consequences of obesity. Am J Public Health. 2016;106(9):1656–62. 10.2105/AJPH.2016.303326 - DOI - PMC - PubMed
    1. Wardle J, Cooke L. The impact of obesity on psychological well-being. Best Pract Res Clin Endocrinol Metab. 2005;19(3):421–40. 10.1016/j.beem.2005.04.006 - DOI - PubMed
    1. Bray GA, Frühbeck G, Ryan DH et al. Management of obesity. Lancet (London, England). 2016;387(10031):1947–56. 10.1016/S0140-6736(16)00271-3 - DOI - PubMed
    1. Andersen JR, Aasprang A, Karlsen T-I et al. Health-related quality of life after bariatric surgery: a systematic review of prospective long-term studies. Surg Obes Related Diseas. 2015;11(2):466–73.10.1016/j.soard.2014.10.027 - DOI - PubMed
    1. Ballantyne GH. Measuring outcomes following bariatric surgery: weight loss parameters, improvement in co-morbid conditions, change in quality of life and patient satisfaction. Obes Surg. 2003;13(6):954–64. 10.1381/096089203322618867 - DOI - PubMed